The Food and Drug Administration needs a new regulatory pathway—something Congress would have to create—to regulate CBD, the agency says. Industry groups disagree, however.
New Hope Network Read More
The Food and Drug Administration needs a new regulatory pathway—something Congress would have to create—to regulate CBD, the agency says. Industry groups disagree, however.
New Hope Network Read More
Sign in to your account